Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects

Telitacicept, an injectable recombinant human B‐lymphocyte stimulating factor receptor‐antibody fusion protein, is a new dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation‐inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. This study evaluates the pharmacokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jing, Fan, Xiaoyun, Su, Yue, Zhou, Huan, Cao, Shugang, Zhu, Xingyu, Zhu, Minhui, He, Cuixia, Wang, Ying, Fan, Ling, Ge, Qin, Zhu, Juan, Liu, Bingyan, Chen, Xiao, Xie, Yunqiu, Ma, Ling, Liu, Yuanyuan, Chen, Juan, Wang, Huaxue, Li, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796261/
https://www.ncbi.nlm.nih.gov/pubmed/35844038
http://dx.doi.org/10.1002/cpdd.1136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796261/
https://www.ncbi.nlm.nih.gov/pubmed/35844038
http://dx.doi.org/10.1002/cpdd.1136

Ejemplares similares